{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:53:04Z","timestamp":1790675584858,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T00:00:00Z","timestamp":1529971200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1245\/s10434-018-6591-6","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T18:41:22Z","timestamp":1530038482000},"page":"3064-3068","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Treatment Outcomes for Pleomorphic Lobular Carcinoma In Situ of the Breast"],"prefix":"10.1245","volume":"25","author":[{"given":"Amita A.","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael E.","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya L.","family":"Hoskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney N.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy C.","family":"Boughey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina J.","family":"Hieken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,26]]},"reference":[{"key":"6591_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/00132583-199605000-00009","volume":"1","author":"AR Frost","year":"1996","unstructured":"Frost AR, Tsangaris TN, Silverberg SG. Pleomorphic lobular carcinoma in situ. Pathol Case Rev. 1996;1:27\u201331.","journal-title":"Pathol Case Rev"},{"key":"6591_CR2","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/1746-1596-8-114","volume":"8","author":"DS Gomes","year":"2013","unstructured":"Gomes DS, Porto SS, Rocha RM, Gobbi H. Usefulness and limitations of E-cadherin and beta-catenin in the classification of breast carcinomas in situ with mixed pattern. Diagn Pathol. 2013;8:114.","journal-title":"Diagn Pathol"},{"issue":"2","key":"6591_CR3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.breast.2013.01.003","volume":"22","author":"YA Masannat","year":"2013","unstructured":"Masannat YA, Baines SK, Pinder SE, Purushotham AD. Challenges in the management of pleomorphic lobular carcinoma in situ of the breast. Breast. 2013;22(2):194\u20136.","journal-title":"Breast"},{"key":"6591_CR4","unstructured":"NCCN Clinical Practice Guidelines in Oncology. Breast Cancer 2018. Accessed 30 Mar 2018; Available at www.NCCN.org ."},{"key":"6591_CR5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.5306\/wjco.v5.i3.546","volume":"5","author":"AJ Pieri","year":"2014","unstructured":"Pieri AJ, Harvey J, Bundred N. Pleomorphic lobular carcinoma in situ of the breast: can the evidence guide practice? World J Clin Oncol. 2014;5:546\u201353.","journal-title":"World J Clin Oncol"},{"key":"6591_CR6","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/tbj.12062","volume":"19","author":"SL Blair","year":"2013","unstructured":"Blair SL, Emerson DK, Kulkarni S, Hwang ES, Malcarne V, Ollila DW. Breast surgeon\u2019s survey: no consensus for surgical treatment of pleomorphic lobular carcinoma in situ. Breast J. 2013;19:116\u20138.","journal-title":"Breast J"},{"key":"6591_CR7","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jamcollsurg.2009.07.026","volume":"209","author":"SL Blair","year":"2009","unstructured":"Blair SL, Thompson K, Rococco J, Malcarne V, Beitsch PD, Ollila DW. Attaining negative margins in breast-conservation operations: is there a consensus among breast surgeons? J Am Coll Surg. 2009;209:608\u201313.","journal-title":"J Am Coll Surg"},{"key":"6591_CR8","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.5858\/2009-0300-OA.1","volume":"134","author":"ME Sullivan","year":"2010","unstructured":"Sullivan ME, Khan SA, Sullu Y, Schiller C, Susnik B. Lobular carcinoma in situ variants in breast cores: potential for misdiagnosis, upgrade rates at surgical excision, and practical implications. Arch Pathol Lab Med. 2010;134:1024\u20138.","journal-title":"Arch Pathol Lab Med"},{"key":"6591_CR9","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/his.12353","volume":"64","author":"T Khoury","year":"2014","unstructured":"Khoury T, Karabakhtsian RG, Mattson D, et al. Pleomorphic lobular carcinoma in situ of the breast: clinicopathological review of 47 cases. Histopathology. 2014;64:981\u201393.","journal-title":"Histopathology"},{"key":"6591_CR10","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1097\/PAS.0b013e3181b18a89","volume":"33","author":"YY Chen","year":"2009","unstructured":"Chen YY, Hwang ES, Roy R, et al. Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol. 2009;33: 1683\u201394.","journal-title":"Am J Surg Pathol"},{"key":"6591_CR11","doi-asserted-by":"publisher","first-page":"4863","DOI":"10.3892\/ol.2016.5331","volume":"12","author":"U Wazir","year":"2016","unstructured":"Wazir U, Wazir A, Wells C, Mokbel K. Pleomorphic lobular carcinoma in situ: current evidence and a systemic review. Oncol Lett. 2016;12:4863\u20134868.","journal-title":"Oncol Lett"},{"key":"6591_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10549-017-4334-1","volume":"165","author":"M Brot De","year":"2017","unstructured":"De Brot M, Koslow MS, Muhsen S, et al. Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review. Breast Cancer Res Treat. 2017;165:411\u2013420.","journal-title":"Breast Cancer Res Treat"},{"key":"6591_CR13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.5858\/2010-0204-OA.1","volume":"135","author":"E Downs-Kelly","year":"2011","unstructured":"Downs-Kelly E, Bell D, Perkins GH, Sneige N, Middleton LP. Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ. Arch Pathol Lab Med. 2011;135:737\u201343.","journal-title":"Arch Pathol Lab Med"},{"key":"6591_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2017.10.004","author":"T Guo","year":"2017","unstructured":"Guo T, Wang Y, Shapiro N, Fineberg S. Pleomorphic lobular carcinoma in situ diagnosed by breast core biopsy: clinicopathologic features and correlation with subsequent excision. Clin Breast Cancer. 2017. https:\/\/doi.org\/10.1016\/j.clbc.2017.10.004 .","journal-title":"Clin Breast Cancer"},{"key":"6591_CR15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/tbj.12843","volume":"4","author":"CE Fasola","year":"2018","unstructured":"Fasola CE, Chen JJ, Jensen KC, Allison KH, Horst KC. Characteristics and clinical outcomes of pleomorphic lobular carcinoma in situ of the breast. Breast J. 2018;4:66\u201369.","journal-title":"Breast J"},{"key":"6591_CR16","doi-asserted-by":"publisher","first-page":"4263","DOI":"10.1245\/s10434-015-4552-x","volume":"22","author":"MR Flanagan","year":"2015","unstructured":"Flanagan MR, Rendi MH, Calhoun KE, Anderson BO, Javid SH. Pleomorphic lobular carcinoma in situ: radiologic-pathologic features and clinical management. Ann Surg Oncol. 2015;22:4263\u20139.","journal-title":"Ann Surg Oncol"},{"key":"6591_CR17","doi-asserted-by":"publisher","first-page":"310","DOI":"10.6004\/jnccn.2018.0012","volume":"16","author":"WJ Gradishar","year":"2018","unstructured":"Gradishar WJ, Anderson BO, Balassanian R, et al. Breast cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16:310\u2013320.","journal-title":"J Natl Compr Canc Netw"},{"key":"6591_CR18","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/S0140-6736(99)05036-9","volume":"353","author":"B Fisher","year":"1999","unstructured":"Fisher B, Dignam J, Wolmark N, et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet. 1999;353:1993\u20132000.","journal-title":"Lancet"},{"key":"6591_CR19","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 study. J Natl Cancer Inst. 1998;90:1371\u201388.","journal-title":"J Natl Cancer Inst"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-018-6591-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6591-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-018-6591-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T12:32:39Z","timestamp":1661517159000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-018-6591-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,26]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["6591"],"URL":"https:\/\/doi.org\/10.1245\/s10434-018-6591-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,26]]},"assertion":[{"value":"23 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}